PNC FINANCIAL SERVICES GROUP, INC. - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 146 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2023$380
-26.9%
1230.0%0.00%
Q4 2022$5201230.0%0.00%
Q3 2022$01230.0%0.00%
Q2 2022$01230.0%0.00%
Q1 2022$0123
+66.2%
0.00%
Q4 2019$0740.0%0.00%
Q3 2019$0
-100.0%
74
-99.9%
0.00%
-100.0%
Q2 2019$1,518,000
-74.2%
119,464
-21.2%
0.00%
-83.3%
Q1 2019$5,879,000151,586
+2526333.3%
0.01%
Q1 2018$060.0%0.00%
Q4 2017$0
-100.0%
6
-99.3%
0.00%
Q2 2017$77,000
+108.1%
880
-12.0%
0.00%
Q1 2017$37,000
+19.4%
1,0000.0%0.00%
Q4 2016$31,000
+416.7%
1,000
+900.0%
0.00%
Q3 2016$6,0000.0%100
-50.0%
0.00%
Q1 2016$6,000
-62.5%
2000.0%0.00%
Q4 2015$16,000
-87.2%
200
-88.0%
0.00%
Q3 2015$125,000
-39.3%
1,666
-5.6%
0.00%
Q2 2015$206,000
+82.3%
1,764
+264.5%
0.00%
Q1 2015$113,000
+79.4%
484
+48.0%
0.00%
Q4 2014$63,000
+103.2%
327
+151.5%
0.00%
Q3 2014$31,000
+520.0%
130
+85.7%
0.00%
Q2 2014$5,000
-66.7%
70
-52.1%
0.00%
Q1 2014$15,000
-81.2%
146
-92.0%
0.00%
Q2 2013$80,0001,8200.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2019
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$4,713,2604.15%
Eversept Partners, LP 1,681,149$4,421,4220.37%
Camber Capital Management LP 4,235,000$11,1380.37%
Kynam Capital Management, LP 473,975$1,246,5540.20%
GLOBEFLEX CAPITAL L P 538,559$1,416,4100.17%
Affinity Asset Advisors, LLC 202,349$532,1780.15%
GSA CAPITAL PARTNERS LLP 279,629$7350.06%
RICE HALL JAMES & ASSOCIATES, LLC 363,666$956,4420.06%
Patriot Financial Group Insurance Agency, LLC 67,000$176,2100.04%
ACADIAN ASSET MANAGEMENT LLC 1,858,000$4,8840.02%
View complete list of PUMA BIOTECHNOLOGY INC shareholders